By Zoë Hopkins Once she was cast out of the United States. Today, her art and activism are front and center at an exhilarating Brooklyn Museum retrospective. By Siddhartha Mitter A planned ...

Actuate Therapeutics has won Food and Drug Administration orphan-drug designation for its lead investigational drug product in a group of rare cancerous tumors. Actuate on Wednesday said the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

These commuters don't need a powerful e-bike with lots of range — they just need a little extra oomph for the occasional hill, say CLIP co-founders Som Ray and Clement de Alcala. For many ...

No matter how powerful generative AI becomes, writer Ted Chiang says it will never create true art. Chiang is one of the most admired science-fiction authors writing today, best known for the ...

CHICAGO and FORT WORTH, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Nasdaq: ACTU) (the “Company”), a clinical stage biopharmaceutical company focused on developing ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Artist Emma Majury demonstrates some basic artistic techniques in the realms of drawing, painting, photography, printing, collage, and sculpture. A series of short films for primary schools ...

Actuate Therapeutics (ACTU) has filed for up to 2,777,778 share offering by selling stockholders.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Elraglusib is a Class-LeadingGSK-3β Inhibitor with a Novel, Multimodal Mechanism of Action in Multiple Refractory Cancer Trials Orphan Drug Designation in Soft Tissue Sarcomas Expands Company’s ...